Guy G. Chabot
Impact in
- Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Flavonoids in Medical Research
Papers in
-
- Bioactive Compounds and Antitumor Agents 6
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 9
- Flavonoids in Medical Research 6
- Co-authors
- Daniel SchermanJulie MarillJohanne SéguinNadia IdresYasmine TouilNathalie MignetRichard L. MomparlerMichel Lanotte
- Journals
- Cancer Chemotherapy and Pharmacology (6 papers)European Journal of Medicinal Chemistry (5 papers)Biochemical Pharmacology (5 papers)Anti-Cancer Drugs (3 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Guy G. Chabot
67 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 117
- Biochemistry 292
- Pharmacology 400
- Pharmacology 476
- Oncology 712
- Molecular Biology 1.6k
Countries citing papers authored by Guy G. Chabot
This map shows the geographic impact of Guy G. Chabot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy G. Chabot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy G. Chabot more than expected).
Fields of papers citing papers by Guy G. Chabot
This network shows the impact of papers produced by Guy G. Chabot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy G. Chabot. The network helps show where Guy G. Chabot may publish in the future.
Co-authors
The 25 scholars most cited alongside Guy G. Chabot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 30 | |
| 2 | 2013 | 120 | |
| 3 | 2013 | 16 | |
| 4 | 2012 | 67 | |
| 5 | 2012 | 36 | |
| 6 | 2012 | 23 | |
| 7 | 2011 | 40 | |
| 8 | 2011 | 34 | |
| 9 | 2011 | 21 | |
| 10 | 2011 | 92 | |
| 11 | 2010 | 24 | |
| 12 | 2009 | 64 | |
| 13 | 2007 | 5 | |
| 14 | 2006 | 27 | |
| 15 | 2000 | 160 | |
| 16 | 1996 | 14 | |
| 17 | 1995 | 11 | |
| 18 | 1995 | 15 | |
| 19 | 1994 | 2 | |
| 20 | 1992 | 71 |
About Guy G. Chabot
Guy G. Chabot is a scholar working on Toxicology, Pharmacology, Biochemistry, Pharmacology and Oncology, having authored 67 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (13 papers), Synthesis and biological activity (9 papers), Pharmacogenetics and Drug Metabolism (9 papers), Retinoids in leukemia and cellular processes (8 papers), Cancer Treatment and Pharmacology (8 papers), Estrogen and related hormone effects (8 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Flavonoids in Medical Research (6 papers). The work is most often cited by research in Biochemistry (292 citations), Pharmacology (400 citations), Pharmacology (476 citations), Oncology (712 citations) and Molecular Biology (1.6k citations). Guy G. Chabot has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Daniel Scherman, Julie Marill, Johanne Séguin, Nadia Idres, Yasmine Touil, Nathalie Mignet, Richard L. Momparler, Michel Lanotte, Lionel Quentin and Maria Flexor. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, European Journal of Medicinal Chemistry, Biochemical Pharmacology, Anti-Cancer Drugs and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.